PPGN — PolyPeptide AG Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapMomentum Trap

Annual balance sheet for PolyPeptide AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	17.5	17.2	136	37.5	95.7
Net Total Accounts Receivable
Net Total Receivables	44.8	65.1	75.9	62.4	96
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	143	180	332	252	327
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	137	170	235	297	324
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	305	376	595	576	689
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	56.3	102	104	96.1	176
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	156	198	174	154	308
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	149	178	421	422	381
Total Liabilities & Shareholders' Equity	305	376	595	576	689
Total Common Shares Outstanding